Breaking News

Ben Venue To Exit CMO Business

Sterile, cyto manufacturer ends after 70+ years of service

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

The management of Ben Venue Laboratories (BVL) has elected to exit the contract manufacturing business. The company manufactured sterile injectables and cytotoxic products and will transition out of that business during the next several years. BVL’s facility in Bedford, OH has been in continuous service since 1938. According to a company statement, “BVL is working with its customers to develop and implement comprehensive long-term transition plans in order to minimize potential impa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters